TQ05105 Tablet for Myelofibrosis Treatment in Ruxolitinib-Resistant or Intolerant Patients
Clinical trial NCT06388759 · TERMINATED
Trial details
- NCT number
- NCT06388759
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2025-08-12
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.